Statin synergizes with LPS to induce IL-1 release by THP-1 cells through activation of caspase-1
It exhibits favorable pharmacokinetics, including a suitable half-life, wide tissue distribution, and effective tissue penetration, critical for eradicating infection at various anatomical sites
It takes part to carry the process of steam sterilization
Importantly, AOD-9604 did not produce any of the adverse effects associated with growth hormone therapy, including glucose intolerance, insulin resistance, edema, joint pain, or tissue growth abnormalities
While current treatments for OCD, such as SSRIs and cognitive-behavioral therapy, work for some, many patients remain treatment-resistant, necessitating alternative therapies